Author:
Janakiraman Sarang,Felice Michael,Pahouja Gaurav,Adams William,Bsatee Aya,Farooq Ahmer,McVary Kevin T.
Funder
National Institute of Allergy and Infectious Diseases
NIH
Reference13 articles.
1. The rising worldwide impact of benign prostatic hyperplasia;Launer;BJU Int,2021
2. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II-surgical evaluation and treatment [published correction appears in J Urol. 2022 Mar;207(3):743];Lerner;J Urol,2021
3. Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia;McVary;J Urol,2021
4. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm(®) system: evaluation of acute ablative capabilities in the human prostate;Dixon;Res Rep Urol,2015
5. Three-year outcomes of the prospective, randomized controlled rezūm system study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia;McVary;Urology,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献